| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $201.5M | +0.5% |
| Cost of Revenue | $97.0M | +8.6% |
| Gross Profit | $104.5M | -6.0% |
| R&D Expense | $36.5M | -7.4% |
| SG&A Expense | $58.9M | +36.7% |
| Operating Income | -$40.4M | -96.8% |
| Pre-tax Income | -$29.8M | -423.5% |
| Income Tax | $36.7M | — |
| Net Income | -$66.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.9M | -8.0% |
| Accounts Receivable | $62.5M | +3.2% |
| Inventory | $48.4M | +10.3% |
| Current Assets | $392.0M | -1.1% |
| Total Assets | $461.5M | -7.6% |
| Current Liabilities | $77.8M | +15.0% |
| Total Liabilities | $119.8M | +15.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.7M | -118.5% |
| Capital Expenditures | $4.1M | +15.9% |
| Investing Cash Flow | $10.1M | +112.2% |
| Financing Cash Flow | -$13.4M | +15.1% |
| Free Cash Flow | -$8.8M | -140.1% |
| -1005.3% |
| Stockholders' Equity |
| $341.7M |
| -13.6% |